NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TTM Capital

TTM Capital

Overview

TTM Capital is a professional investment firm focusing on early and growth-stage investments in the life science and healthcare sectors, including biopharmaceuticals, medical devices, and in vitro diagnostics.

Year Founded

2020

Portfolio Companies

2

Investments

TTM Capital investments
CompanyDateStageLead
NeuShen TherapeuticsJan 2026Series A ExtensionCo-investor
NeuShen TherapeuticsApr 2025Series ACo-investor
RayTheraApr 2025Series ACo-investor
NeuShen TherapeuticsSep 2022Pre SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersShanghai
Year Founded2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.